Eiger BiopharmaceuticalsEIGRQ
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$2.89avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Eiger Biopharmaceuticals Inc. (EIGRQ) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Propel Bio Management, LLC ($423K).
- Company
- Eiger Biopharmaceuticals Inc.
- CUSIP
- 28249U204
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Propel Bio Management, LLC | 0.49% | No change | 146,381 | $423K |
"% of holder's portfolio" is EIGRQ's weight in each manager's 13F, not the share of Eiger Biopharmaceuticals Inc. the manager owns.